Education
About Us
Working with TipRanks
Follow Us
Sotera Health Company (SHC)
NASDAQ:SHC
SHC Stock Chart & Stats
$17.40
-$0.21(-1.56%)
At close: 4:00 PM EST
$17.40
-$0.21(-1.56%)
Day’s Range― - ―
52-Week Range$9.53 - $19.85
Previous CloseN/A
Volume149.43K
Average Volume (3M)1.47M
Market Cap
$4.52B
Enterprise Value$6.45B
Total Cash (Recent Filing)$346.46M
Total Debt (Recent Filing)$2.27B
Price to Earnings (P/E)58.7
Beta0.98
Next Earnings
Apr 30, 2026EPS Estimate
0.18Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.26
Shares Outstanding284,392,100
10 Day Avg. Volume1,622,077
30 Day Avg. Volume1,474,827
Financial Highlights & Ratios
PEG Ratio0.93
Price to Book (P/B)8.27
Price to Sales (P/S)4.30
P/FCF Ratio33.58
Enterprise Value/Market Cap1.43
Enterprise Value/Revenue5.55
Enterprise Value/Gross Profit10.00
Enterprise Value/Ebitda14.44
Forecast
1Y Price Target
$22.20Price Target Upside27.59% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
EPS Forecast (FY)0.96
Revenue Forecast (FY)$1.24B
Bulls Say, Bears Say
Bulls Say
Capacity ExpansionA planned X-ray sterilization facility is expected to broaden service offerings and increase sterilization capacity, supporting faster growth as demand recovers.
Cross-selling And Cash FlowReinvigorated cross-selling combined with stronger pricing and cost control should expand margins and boost free cash flow by increasing sales to existing customers and improving utilization.
Earnings PerformanceQuarterly results beat expectations on revenue, profitability and earnings per share as strong volume growth in sterilization and core lab testing lifted margins and earnings.
Bears Say
Legal RiskUnresolved ethylene oxide litigation with trials scheduled in multiple jurisdictions remains a material overhang that could create financial and operational uncertainty.
Regulatory HeadwindsRegulatory compliance delays are limiting customers' outsourcing shifts, which could constrain near-term volume growth for sterilization services.
Supply And Ownership ConcentrationConcentration of critical suppliers and potential constraints on capacity expansion, together with significant private equity ownership that could lead to equity sales, increase downside pressure on the stock.
Sotera Health News
SHC FAQ
What was Sotera Health Company’s price range in the past 12 months?
Sotera Health Company lowest stock price was $9.53 and its highest was $19.85 in the past 12 months.
What is Sotera Health Company’s market cap?
Sotera Health Company’s market cap is $4.52B.
When is Sotera Health Company’s upcoming earnings report date?
Sotera Health Company’s upcoming earnings report date is Apr 30, 2026 which is in 58 days.
How were Sotera Health Company’s earnings last quarter?
Sotera Health Company released its earnings results on Feb 24, 2026. The company reported $0.26 earnings per share for the quarter, beating the consensus estimate of $0.242 by $0.018.
Is Sotera Health Company overvalued?
According to Wall Street analysts Sotera Health Company’s price is currently Undervalued.
Does Sotera Health Company pay dividends?
Sotera Health Company does not currently pay dividends.
What is Sotera Health Company’s EPS estimate?
Sotera Health Company’s EPS estimate is 0.18.
How many shares outstanding does Sotera Health Company have?
Sotera Health Company has 284,392,100 shares outstanding.
What happened to Sotera Health Company’s price movement after its last earnings report?
Sotera Health Company reported an EPS of $0.26 in its last earnings report, beating expectations of $0.242. Following the earnings report the stock price went down -4.403%.
Which hedge fund is a major shareholder of Sotera Health Company?
Currently, no hedge funds are holding shares in SHC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Sotera Health Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$22.20 (27.59% Upside)
$22.20 (27.59% Upside)
Blogger Sentiment
Bullish
SHC Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 5.2M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $276.9M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 0.9%
Last 30 Days ▲ 5.5%
Last 30 Days ▲ 5.5%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
32.32%
12-Months-Change
Fundamentals
Return on Equity
15.42%
Trailing 12-Months
Asset Growth
6.77%
Trailing 12-Months
Company Description
Sotera Health Company
Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.
SHC Company Deck
SHC Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call communicated solid operational and financial progress: full-year revenue and adjusted EBITDA growth, margin expansion (~118 bps), strong free cash flow ($210M), reduced leverage (3.2x), lowered interest costs and concrete commercial and regulatory achievements (customer satisfaction >80%, Nordion license renewal, XBU growth). Offsetting items were notable: Nordion experienced a sizable quarter-over-quarter revenue and income decline due to harvest timing, Nelson Labs faced advisory headwinds and Q1 softness, Sterigenics has a weaker commercial cohort and a soft start to 2026, and near-term margin/CapEx pressure from greenfield X-ray build and rising depreciation. Overall, the positives (consistent growth, margin expansion, cash generation, balance sheet improvements and clear guidance) outweigh the transitory and segment-specific headwinds.View all SHC earnings summariesSHC Stock 12 Month Forecast
Average Price Target
$22.20
▲(27.59% Upside)
Technical Analysis
Ownership Overview
Currently, No data available
---